Statistics for Lumos Pharma (id:6995 LUMO)

Valuation metrics

Market cap

37.45M

Enterprise value

24.02M

Trailing P/E (ttm)

-1.03

Forward P/E

-2.00

PEG ratio

-2.00

Price/Sales (ttm)

16.98

Price/Book (mrq)

7.62

Enterprise Value/Revenue

10.89

Enterprise Value/EBITDA

-0.66

Overview

Shares outstanding

8.65M

Float

5.66M

Shares short

86.38K

% Held by insiders

0.33%

% Held by institutions

0.24%

Average volume (10 days)

107.51K

Average volume (90 days)

Price summary

52-Week low

1.37

52-Week high

4.58

52-Week change

28.39%

Beta

0.33

50-Day moving average

4.06

200-Day moving average

2.99

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

March 19th, 2020

Ex-dividend date

Last split factor

2:1

Last split date

March 19th, 2020

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-1,052.34%

Operational effectiveness

Return on assets

-69.64%

Return on equity

-172.83%

Income statement

Revenue (ttm)

0.27

Revenue per share (ttm)

0.27

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-36,308,000.00

Net income to common (ttm)

-34,916,000.00

Diluted EPS (ttm)

-4.28

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

13.52M

Total cash per share (mrq)

1.56

Total debt (mrq)

172.00K

Total Debt/Equity (mrq)

3.50

Current ratio (mrq)

265.50%

Book value per share (mrq)

0.57

Cash flow

Cash flow statement

-31,673,000.00

Levered free cash flow (LFCF)

-19,431,624.00